Rymedi Stock

Provider that utilizes blockchain technology to automate diagnostic data tracking and clinical trial supply chains.

Buy

Buy Rymedi shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Rymedi shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Rymedi provides blockchain-based solutions to streamline and digitize healthcare data management, focusing on areas such as toxicology testing and paperless documentation. The company enables organizations to securely manage and share sensitive health information through its digital platform.

Sector

Healthcare & Life Sciences

Founded

2018

Headquarters

Greenville, SC

Buy

Buy Rymedi shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Rymedi shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Rymedi Management Team

Rymedi people and management

  • Co-Founder, CEO
    David Stefanich
  • Co-Founder, CSO
    Jason Cross
  • CRO
    Deepak Hadpawat

Rymedi Valuations & Financials

Gain Insights Into Rymedi Stock Valuation & Share Prices

View real-time NPM data on Rymedi stock including daily Rymedi stock price estimates, valuation history, and historical share price information. Access Rymedi financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Rymedi pricing across six independent market signals. Looking for private company due diligence data sources on Rymedi? Get in touch to learn more.

Similar Companies

Explore companies

like Rymedi

  • Spring Health-Logo

    Spring Health

    Healthcare & Life Sciences

    Mental healthcare solutions for employers and health plans.

  • Zocdoc-Logo

    ZocDoc

    Healthcare & Life Sciences

    Online appointment booking, reminders, paperwork services, and specialty care options.

  • Clarify Health Solutions-Logo

    Clarify

    Healthcare & Life Sciences

    Delivers actionable insights from complex medical data to support better care and operational decisions.

  • Cedar Inc-Logo

    Cedar

    Healthcare & Life Sciences

    The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

  • TurtleTree

    Healthcare & Life Sciences

    Biotech company focused on creating sustainable and innovative nutrition solutions.

  • AnimalBiome

    Healthcare & Life Sciences

    Dedicated to improving the health of cats and dogs through microbiome science.

  • Truveta

    Healthcare & Life Sciences

    A healthcare data analytics platform that aggregates anonymized health data from various providers.

  • Altos Labs

    Healthcare & Life Sciences

    Pioneers cellular reprogramming to extend lifespan by reversing aging effects through advanced regenerative technologies.

  • Cleerly

    Healthcare & Life Sciences

    Offers an advanced heart disease care solution.

FAQ

Questions?

We have answers

Buy Rymedi Stock

Rymedi stock does not trade on public stock exchanges. Rymedi stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Rymedi stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Rymedi Stock

Rymedi Stock does not trade on public stock exchanges. In order to sell Rymedi shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Rymedi Stock Price

Rymedi does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Rymedi share price and other valuable private market data.

Read more about secondary market private company stock prices:

Rymedi Stock Ticker Symbol

There is no ticker symbol for Rymedi stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Rymedi Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Rymedi stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Rymedi Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Rymedi stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Rymedi Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Rymedi IPO

Rymedi is a private company and has not had an IPO. There is currently no Rymedi IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Rymedi IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.